OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis $0.06 0.00 (-2.61%) As of 11/18/2026 03:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsSEC Filings About MariMed Stock (OTCMKTS:MRMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MariMed alerts:Sign Up Key Stats Today's Range$0.05▼$0.0650-Day Range$0.05▼$0.0852-Week Range$0.05▼$0.16Volume425,149 shsAverage Volume1.05 million shsMarket Capitalization$22.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview MariMed, Inc. is a U.S. cannabis company that cultivates, processes, manufactures and sells cannabis products for medical and adult-use markets. Its operations include cultivation and production facilities as well as retail dispensaries in multiple states. The company offers cannabis flower, concentrates, edibles and other products through brands including Nature’s Heritage, Betty’s Eddies and Bubby’s Baked. Its dispensaries sell products to consumers in the markets where MariMed operates. MariMed traces its roots to the early 2010s, when it began providing management and operational services to cannabis businesses before expanding into owning and operating cannabis operations. Its business is focused on serving state-regulated markets in the United States.AI Generated. May Contain Errors. Read More MariMed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreMRMD MarketRank™: 0.61232876712 of 5 starsMariMed scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingMariMed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageMariMed has received no research coverage in the past 90 days.Read more about MariMed's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioMariMed has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of MariMed has been sold short.Short Interest Ratio / Days to CoverMariMed has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MariMed has recently increased by 1,748.60%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMariMed does not currently pay a dividend.Dividend GrowthMariMed does not have a long track record of dividend growth. News and Social Media1.4 / 5News SentimentN/A News SentimentMariMed has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MariMed insiders have not sold or bought any company stock.Percentage Held by Insiders16.05% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.18% of the stock of MariMed is held by institutions.Read more about MariMed's insider trading history. Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRMD Stock News HeadlinesMariMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 12, 2026 | marketscreener.comMMariMed Reports Third Quarter 2026 EarningsNovember 11, 2026 | globenewswire.comYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.November 19 at 1:00 AM | Reagan Gold Group (Ad)Thrive Dispensaries Awards $20,000 to Support Veterans Facing Housing Challenges through Annual Help on the Homefront CampaignNovember 11, 2026 | globenewswire.comMariMed Q3 earnings previewNovember 10, 2026 | msn.comEarnings To Watch: MariMed Inc (MRMD) Q3 2026 -- GF Value Sees 86% UpsideNovember 10, 2026 | finance.yahoo.comMariMed (OTCMKTS:MRMD) Stock Breaks Above 200 Day Moving Average - Here's WhyNovember 10, 2026 | americanbankingnews.comMariMed (MRMD) Projected to Post Quarterly Earnings on WednesdayNovember 10, 2026 | americanbankingnews.comSee More Headlines MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed this year? MariMed's stock was trading at $0.0879 at the beginning of 2026. Since then, MRMD shares have decreased by 36.3% and is now trading at $0.0560. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday, November, 11th. The company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The company had revenue of $44.23 million for the quarter, compared to analyst estimates of $41.20 million. MariMed had a negative net margin of 9.27% and a negative trailing twelve-month return on equity of 13.19%. Read the conference call transcript. How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Curaleaf (CURLF), Charlotte's Web (CWBHF), MedMen Enterprises (MMNFF) and Organigram Global (OGI). Company Calendar Last Earnings11/11/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:MRMD Previous SymbolOTC:MRMD CIK1522767 Webmarimedinc.com Phone(617) 795-5140FaxN/AEmployees866Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.48 million Net Margins-9.27% Pretax Margin-6.42% Return on Equity-13.19% Return on Assets-2.97% Debt Debt-to-Equity Ratio1.90 Current Ratio0.90 Quick Ratio0.34 Sales & Book Value Annual Sales$159.83 million Price / Sales0.14 Cash Flow$0.02 per share Price / Cash Flow2.48 Book Value$0.10 per share Price / Book0.56Miscellaneous Outstanding Shares402,950,000Free Float338,281,000Market Cap$22.57 million OptionableNot Optionable Beta1.54 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:MRMD) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredThe Democrats can’t stop thisPorter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypass...Porter & Company | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.